These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11120527)

  • 1. Reductions of vascular endothelial growth factor and placental growth factor concentrations in severe preeclampsia.
    Livingston JC; Chin R; Haddad B; McKinney ET; Ahokas R; Sibai BM
    Am J Obstet Gynecol; 2000 Dec; 183(6):1554-7. PubMed ID: 11120527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placenta growth factor is not an early marker for the development of severe preeclampsia.
    Livingston JC; Haddad B; Gorski LA; Neblett P; Ahokas RA; Ramsey R; Sibai BM
    Am J Obstet Gynecol; 2001 May; 184(6):1218-20. PubMed ID: 11349191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second-trimester maternal serum placental growth factor and vascular endothelial growth factor for predicting severe, early-onset preeclampsia.
    Polliotti BM; Fry AG; Saller DN; Mooney RA; Cox C; Miller RK
    Obstet Gynecol; 2003 Jun; 101(6):1266-74. PubMed ID: 12798535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies.
    Taylor RN; Grimwood J; Taylor RS; McMaster MT; Fisher SJ; North RA
    Am J Obstet Gynecol; 2003 Jan; 188(1):177-82. PubMed ID: 12548214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal plasma vascular endothelial growth factor concentrations in normal and hypertensive pregnancies and their relationship to peripheral vascular resistance.
    Bosio PM; Wheeler T; Anthony F; Conroy R; O'herlihy C; McKenna P
    Am J Obstet Gynecol; 2001 Jan; 184(2):146-52. PubMed ID: 11174494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence supporting that the excess of the sVEGFR-1 concentration in maternal plasma in preeclampsia has a uterine origin.
    Bujold E; Romero R; Chaiworapongsa T; Kim YM; Kim GJ; Kim MR; Espinoza J; Gonçalves LF; Edwin S; Mazor M
    J Matern Fetal Neonatal Med; 2005 Jul; 18(1):9-16. PubMed ID: 16105786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal plasma VEGF, sVEGF-R1, and PlGF concentrations in preeclamptic and normotensive pregnant Zimbabwean women.
    Muy-Rivera M; Vadachkoria S; Woelk GB; Qiu C; Mahomed K; Williams MA
    Physiol Res; 2005; 54(6):611-22. PubMed ID: 15717861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective deficit of angiogenic growth factors characterises pregnancies complicated by pre-eclampsia.
    Reuvekamp A; Velsing-Aarts FV; Poulina IE; Capello JJ; Duits AJ
    Br J Obstet Gynaecol; 1999 Oct; 106(10):1019-22. PubMed ID: 10519425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal plasma levels of cytokines in normal and preeclamptic pregnancies and their relationship with diastolic blood pressure and fibronectin levels.
    Madazli R; Aydin S; Uludag S; Vildan O; Tolun N
    Acta Obstet Gynecol Scand; 2003 Sep; 82(9):797-802. PubMed ID: 12911439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia.
    Baker PN; Krasnow J; Roberts JM; Yeo KT
    Obstet Gynecol; 1995 Nov; 86(5):815-21. PubMed ID: 7566855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Maternal serum concentration of placental growth factor (PIGF) and endothelial growth factor (VEGF) in pregnancies complicated by preeclampsia].
    Semczuk-Sikora A; Krzyzanowski A; Kwiatek M; Semczuk M
    Ginekol Pol; 2007 Nov; 78(11):873-6. PubMed ID: 18306920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placental growth factor and vascular endothelial growth factor serum levels in Tunisian Arab women with suspected preeclampsia.
    Ben Ali Gannoun M; Bourrelly S; Raguema N; Zitouni H; Nouvellon E; Maleh W; Brahim Chemili A; Elfeleh R; Almawi W; Mahjoub T; Gris JC
    Cytokine; 2016 Mar; 79():1-6. PubMed ID: 26702929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of placenta growth factor and soluble Fms-like tyrosine kinase 1 receptor levels in mild and severe preeclampsia.
    Robinson CJ; Johnson DD; Chang EY; Armstrong DM; Wang W
    Am J Obstet Gynecol; 2006 Jul; 195(1):255-9. PubMed ID: 16813756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placental growth factor (PlGF) is a surrogate marker in preeclamptic hypertension.
    Teixeira PG; Cabral AC; Andrade SP; Reis ZS; da Cruz LP; Pereira JB; Martins BO; Rezende CA
    Hypertens Pregnancy; 2008; 27(1):65-73. PubMed ID: 18293205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia.
    Koga K; Osuga Y; Yoshino O; Hirota Y; Ruimeng X; Hirata T; Takeda S; Yano T; Tsutsumi O; Taketani Y
    J Clin Endocrinol Metab; 2003 May; 88(5):2348-51. PubMed ID: 12727995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examining the correlation between placental and serum placenta growth factor in preeclampsia.
    Weed S; Bastek JA; Anton L; Elovitz MA; Parry S; Srinivas SK
    Am J Obstet Gynecol; 2012 Aug; 207(2):140.e1-6. PubMed ID: 22704767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor is increased in patients with preeclampsia.
    Kupferminc MJ; Daniel Y; Englender T; Baram A; Many A; Jaffa AJ; Gull I; Lessing JB
    Am J Reprod Immunol; 1997 Oct; 38(4):302-6. PubMed ID: 9352019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and in pre-eclampsia.
    Lyall F; Greer IA; Boswell F; Fleming R
    Br J Obstet Gynaecol; 1997 Feb; 104(2):223-8. PubMed ID: 9070144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor serum levels in pregnancy and preeclampsia.
    Hefler L; Obermair A; Husslein P; Kainz C; Tempfer C
    Acta Obstet Gynecol Scand; 2000 Jan; 79(1):77-8. PubMed ID: 10646821
    [No Abstract]   [Full Text] [Related]  

  • 20. [Angiogenic proteins: possible markers of physiopathological processes during fetal development].
    Petersen TM; Larsen T; Nielsen HJ
    Ugeskr Laeger; 2003 Aug; 165(32):3082-7. PubMed ID: 12951850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.